Myungmun Pharma
KOSPI · Healthcare · ₩42B
₩1,242+0.65%
Price
1307.0원
1242.0원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩51.2B+6.7%
Operating Income-₩836MTurned to loss
Net Income-₩1.7B-63.1%
3/'26 vs prev quarter
Company Health
Market Cap₩42B
Operating Margin+0.8%
Cash on Hand243억원58.0% of market cap
Free Cash Flow-38억원-9.1% of market cap
Short Volume 3.6% · as of 26.09.11
Among 98 제약 peers
LowMedianHigh
PSR0.2xmedian 0.8xPBR0.5xmedian 0.8xROE-2.6%median +4.9%
